Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue

January 7, 2024

https://www.globenewswire.com/news-release/2024/01/07/2805022/0/en/Singular-Genomics-Reports-Instrument-Shipments-and-Preliminary-Unaudited-Fourth-Quarter-2023-Revenue.html

SAN DIEGO, Jan. 07, 2024 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced instrument shipments and preliminary unaudited revenue for the fourth quarter of 2023.

Read more at globenewswire.com

Related news for (OMIC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.